CVS Takes Aim at Private Label Biosimilars With New Subsidiary Cordavis

CVS Health has launched a subsidiary, Cordavis, to work directly with manufacturers to commercialize and/or co-produce FDA-approved biosimilar products at more affordable prices.
Source: Drug Industry Daily